HIV treatment resources and HIV ongoing care support can help individuals understand their treatment plan, attend recommended appointments, manage medicines, and address other health needs. The exact resources . . .
Researchers can now examine biological systems at increasingly detailed levels, including genes, proteins, cells, and molecular pathways. These developments support a more detailed understanding of biological variation and . . .
HIV drug resistance testing is used in several clinical situations, including around the time HIV is diagnosed and when treatment is not producing the expected level of viral . . .
HIV drug resistance testing is used in several clinical situations, including around the time HIV is diagnosed and when treatment is not producing the expected level of viral . . .
In June 2025, the U.S. Food and Drug Administration approved injectable lenacapavir for HIV PrEP, and in July 2025, the World Health Organization recommended twice-yearly injectable lenacapavir as . . .
In June 2025, the U.S. Food and Drug Administration approved injectable lenacapavir for HIV PrEP, and in July 2025, the World Health Organization recommended twice-yearly injectable lenacapavir as . . .
It explains HIV drug classes comparison points, outlines ART regimen options used in practice, and reviews HIV viral suppression strategies. It also summarizes long-acting HIV therapies . . .
It explains HIV drug classes comparison points, outlines ART regimen options used in practice, and reviews HIV viral suppression strategies. It also summarizes long-acting HIV therapies . . .
It explains HIV drug classes comparison points, outlines ART regimen options used in practice, and reviews HIV viral suppression strategies. It also summarizes long-acting HIV therapies . . .
This Alpha 1 Antitrypsin Deficiency Disease Overview examines the condition from a general medical and educational perspective. It explains the role of alpha-1 antitrypsin, the genetic . . .